Propiedad y actividad de insiders de Anavex Life Sciences Corp. (AVXL): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $2.36 |
| Capitalización | $219M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-05-04 | Kellmeyer Terrie | 46,668 | $336K | |
| 2026-05-04 | Kellmeyer Terrie | 7,500 | $40K | |
| 2026-05-04 | Kellmeyer Terrie | 50,000 | $429K | |
| 2026-02-23 | Paeger Axel | |||
| 2026-01-06 | MISSLING CHRISTOPHER U | A-Award | 125,000 | $1.1M |
| 2026-01-06 | Boenisch Sandra | A-Award | 12,500 | $107K |
| 2025-10-02 | Boenisch Sandra | A-Award | 12,500 | $67K |
| 2025-10-02 | MISSLING CHRISTOPHER U | A-Award | 125,000 | $670K |
| 2025-09-11 | MISSLING CHRISTOPHER U | M-Exempt | 187,500 | $945K |
| 2025-09-11 | MISSLING CHRISTOPHER U | F-InKind | 145,048 | $1.4M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $9.2M | $27.4M | $22.9M | $22.2M | $29.2M | $152.1M | $149.2M | $151.0M | $132.2M | $102.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $79347 | $9748 | $1.9M | $2.6M | $4.8M | $9.1M | $3.2M | $2.7M | $2.4M | $809000 |
| Inventario | 0 | 0 | 0 | -$2.6M | 0 | $16365 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $9.4M | $27.8M | $24.3M | $25.3M | $34.5M | $161.6M | $152.7M | $154.4M | $135.6M | $103.8M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $9.5M | $27.8M | $24.4M | $25.3M | $34.5M | $161.6M | $152.7M | $154.4M | $135.6M | $103.8M |
| Cuentas por Pagar | $3.1M | $3.6M | $3.0M | $3.5M | $4.0M | $4.7M | $3.8M | $4.3M | $9.6M | $4.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.2M | $3.6M | $3.9M | $5.0M | $7.3M | $10.8M | $10.2M | $12.5M | $15.3M | $8.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $3.2M | $3.6M | $3.9M | $5.0M | $7.3M | $10.8M | $10.2M | $12.5M | $15.3M | $8.9M |
| Reservas | -$78.0M | -$91.5M | -$108.9M | -$133.4M | -$159.7M | -$197.6M | -$245.6M | -$293.1M | -$336.1M | -$382.4M |
| Patrimonio Neto | $6.3M | $24.3M | $20.5M | $20.3M | $27.2M | $150.8M | $142.5M | $141.9M | $120.3M | $94.9M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$9.2M | -$27.4M | -$22.9M | -$22.2M | -$29.2M | -$152.1M | -$149.2M | -$151.0M | -$132.2M | -$102.6M |
| Capital Circulante | $6.3M | $24.2M | $20.4M | $20.3M | $27.2M | $150.8M | $142.5M | $141.9M | $120.3M | $94.9M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 15.62 |
Rentabilidad
| Rentabilidad sobre capital | -21.11% |
| Rentabilidad sobre capital invertido | -27.25% |
| Rentabilidad sobre activos | -20.01% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ABSI · ARVN · ATXS · CTMX · ERAS · MBX · MGTX
Explorar sector: Healthcare · Biotechnology
Más secciones de AVXL: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones